Regeneron Pharmaceuticals (NASDAQ:REGN) Q3 2026 Earnings Call
Regeneron Pharmaceuticals (NASDAQ:REGN) reports Q3 2026 results on this call. Live coverage runs here, and the full replay with transcript and chapters lands on this page after the call.
- Company
- Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
- Period
- Q3 2026 earnings call
- Date
- Fri, Oct 30, 2026, 8:30 AM ET
On 6ix: 6ix.com/event/regeneron-pharmaceuticals-inc-regn-q3-2026-earnings-call
Latest news releases
- NASDAQ:REGN — Libtayo® (cemiplimab) Recommended for EU Approval by the CHMP for Updated Dosing Regimen Across All Approved Cancer Types · Fri, Oct 16, 2026
- NASDAQ:REGN — Regeneron Showcases Advances in Care Across Several Cancers and Cancer-associated Complications at ESMO 2026 · Tue, Oct 6, 2026